Therefore, this study suggests that the administration of imipramine when severe hypoglycemia occurs in diabetic patients prescribed insulin could be a potentially promising therapeutic approach to prevent hippocampal neuronal death and cognitive deficit during hypoglycemia/glucose reperfusion. Here, INS is linked to Cognitive impairment.